• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Patiromer
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    not in the basket chart

    Drugs for treatment of hyperkalaemia and hyperphosphataemia. Patiromer 8.4 g, 16.8 g.
    SACHET. (Pwdr. for oral susp.): 30. The recommended init. dose is 8.4 g×1/d.
    The dly. dose may be adjust. in intervals of 1 wk. or longer, based on the serum K+ level and the desired target range. The dly. dose may be incr. or decreas. by 8.4 g as necessary to reach the desired target range, up to a max. dose of 25.2 g dly.
    If serum K+ falls below the desired range, the dose should be reduced or discont.
    If a dose is missed, the missed dose should be taken as soon as possible on the same day. The missed dose should not be taken with the next dose.
    Admin. be separated by 3 hrs. from other oral med. products.
    The onset of action of Patiromer occurs 4-7 hrs. after admin. Patiromer should not replace emergency tmt. for life-threaten. hyperkalaem.
    Treatment of hyperkalaemia in adults.
    C/I: Hypersens.